Department of Pediatric Neurology, Faculty of Medical Sciences, Medical University of Silesia, 40-752 Katowice, Poland.
Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland.
Genes (Basel). 2023 Apr 25;14(5):972. doi: 10.3390/genes14050972.
(kinesin family member 1A)-related disorders encompass a variety of diseases. variants are responsible for autosomal recessive and dominant spastic paraplegia 30 (SPG, OMIM610357), autosomal recessive hereditary sensory and autonomic neuropathy type 2 (HSN2C, OMIM614213), and autosomal dominant neurodegeneration and spasticity with or without cerebellar atrophy or cortical visual impairment (NESCAV syndrome), formerly named mental retardation type 9 (MRD9) (OMIM614255). variants have also been occasionally linked with progressive encephalopathy with brain atrophy, progressive neurodegeneration, PEHO-like syndrome (progressive encephalopathy with edema, hypsarrhythmia, optic atrophy), and Rett-like syndrome.
The first Polish patients with confirmed heterozygous pathogenic and potentially pathogenic variants were analyzed. All the patients were of Caucasian origin. Five patients were females, and four were males (female-to-male ratio = 1.25). The age of onset of the disease ranged from 6 weeks to 2 years.
Exome sequencing identified three novel variants. Variant c.442G>A was described in the ClinVar database as likely pathogenic. The other two novel variants, c.609G>C; p.(Arg203Ser) and c.218T>G, p.(Val73Gly), were not recorded in ClinVar.
The authors underlined the difficulties in classifying particular syndromes due to non-specific and overlapping signs and symptoms, sometimes observed only temporarily.
(驱动蛋白家族成员 1A)相关疾病包括多种疾病。 变体负责常染色体隐性和显性痉挛性截瘫 30(SPG,OMIM610357)、常染色体隐性遗传性感觉和自主神经病 2 型(HSN2C,OMIM614213)以及常染色体显性神经退行性疾病伴痉挛,伴或不伴小脑萎缩或皮质视觉障碍(NESCAV 综合征),以前称为智力低下 9 型(MRD9)(OMIM614255)。 变体也偶尔与进行性脑萎缩伴脑病、进行性神经退行性疾病、PEHO 样综合征(伴脑水肿、高度失律、视神经萎缩的进行性脑病)和 Rett 样综合征有关。
分析了经证实的杂合致病性和潜在致病性 变体的首批波兰患者。所有患者均为白种人。五名患者为女性,四名患者为男性(女性与男性的比例为 1.25)。疾病的发病年龄从 6 周至 2 岁不等。
外显子组测序鉴定了三个新变体。变体 c.442G>A 在 ClinVar 数据库中被描述为可能致病性。另外两个新变体 c.609G>C;p.(Arg203Ser)和 c.218T>G,p.(Val73Gly),未在 ClinVar 中记录。
作者强调了由于非特异性和重叠的症状和体征,有时仅暂时观察到,因此难以对特定综合征进行分类。